CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study.

Autor: Frezza, Anna Maria¹ (AUTHOR) annamaria.frezza@istitutotumori.mi.it, Stacchiotti, Silvia¹ (AUTHOR), Chibon, Frederic² (AUTHOR), Coindre, Jean‐Michelle³ (AUTHOR), Italiano, Antoine⁴ (AUTHOR), Romagnosa, Cleofe⁵ (AUTHOR), Bagué, Silvia⁶ (AUTHOR), Dei Tos, Angelo Paolo⁷ (AUTHOR), Braglia, Luca⁸ (AUTHOR), Palmerini, Emanuela⁹ (AUTHOR), Quagliuolo, Vittorio¹⁰ (AUTHOR), Broto, Javier Martin¹¹ (AUTHOR), Lopez Pousa, Antonio¹² (AUTHOR), Grignani, Giovanni¹³ (AUTHOR), Brunello, Antonella¹⁴ (AUTHOR), Blay, Jean‐Yves¹⁵ (AUTHOR), Beveridge, Robert Diaz¹⁶ (AUTHOR), Lugowska, Iwona¹⁷ (AUTHOR), Lesluyes, Tom² (AUTHOR), Maestro, Roberta¹⁸ (AUTHOR)

Publikováno v: Cancer Medicine. Jan2023, Vol. 12 Issue 2, p1350-1357. 8p.

CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma

Autor: Brunac, Anne-Cécile, Fourquet, Joanna, Perot, Gaëlle, Jaffrelot, Marion, Meilleroux, Julie, Danjoux, Marie, Filleron, Thomas, Nicolaï, Vincent, Guimbaud, Rosine, Icher, Samira, Farés, Nadim, Selves, Janick, Chibon, Frédéric

Publikováno v: In Modern Pathology December 2022 35(12):2002-2010

Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial

Autor: Thomas Filleron, Sophie Le Guellec, Christine Chevreau, Bastien Cabarrou, Tom Lesluyes, Sabrina Lodin, Angélique Massoubre, Muriel Mounier, Muriel Poublanc, Frédéric Chibon, Thibaud Valentin

Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

Abstract Background The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of ac

Externí odkaz: https://doaj.org/article/95159104642d44afbaa194669e03e23a

Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03).

Autor: Jakob J; Department of General‑, Visceral- and Paediatric Surgery, University Medical Center Göttingen, 37099, Göttingen, Germany. Jens.jakob@med.uni-goettingen.de., Lesluyes T; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Simeonova-Chergou A; Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany., Wenz F; University Medical Center, University of Freiburg, Freiburg, Germany., Hohenberger P; Department of Surgery, University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany., Chibon F; INSERM U1037, Cancer Research Center in Toulouse (CRCT), 31037, Toulouse, France., Le Guellec S; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2020 Mar; Vol. 196 (3), pp. 280-285. Date of Electronic Publication: 2019 Nov 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.